. "5. Predictions of Vaccine Development." New Vaccine Development: Establishing Priorities: Volume II, Diseases of Importance in Developing Countries. Washington, DC: The National Academies Press, 1986.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
New Vaccine Development: Establishing Priorities, Volume II, Diseases of Importance in Developing Countries
Time to Licensure (years)
Time to Adoption (years)
Efficacy
Number of doses
Cost per dose (dollars)
10
2
0.85
1
12
10
2
0.75
(against strains in vaccine)
Approx. 3
5–10
10
2
0.80
(against strains in vaccine)
1–2
1–2
3
5
0.90
2 (with DTP)
5–10
4
5
(as part of combination)
0.90
1
15
5
5
0.90
3
20
1
2
(dependent on price)
0.90
3
30
6–8
2–3
0.80
2
(boosters required with all current; none gives life-long immunity)